Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients: A Randomized Clinical Trial

NCT01395823 is registered in ClinicalTrials.gov with Dialysis Clinic, Inc. as lead sponsor.

NCT NCT01395823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01395823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients: A Randomized Clinical Trial
Lead sponsor
Dialysis Clinic, Inc.
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2015
Enrollment
470 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease